Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder.[L6010,L52145]
Synonyms
(S)-(+)-β-phenylisopropylamine
Dexamfetamine
(S)-1-phenyl-2-propylamine
(+)-α-methylphenethylamine
(S)-amphetamine
Dextroamphetamine adipate
(+)-amphetamine
(S)-α-methylbenzeneethanamine
Dexamfetaminum
Dexamphetamine
(+)-α-methylphenylethylamine
Dextroamphetamine sulfate
(S)-(+)-amphetamine
d-amphetamine
(+)-(S)-amphetamine
(S)-1-phenyl-2-aminopropane
Desamfetamina
Dexamfetamina
Dextroamphetamine saccharate
Dextroamphetamine
(αS)-α-methylbenzeneethanamine
Dexanfetamina
Brand Names
Apo-dextroamphetamine SR
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682